These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

259 related items for PubMed ID: 8556566

  • 1. Comparison of the effects of salmeterol and salbutamol on clinical activity and eosinophil cationic protein serum levels during the pollen season in atopic asthmatics.
    Di Lorenzo G, Morici G, Norrito F, Mansueto P, Melluso M, Purello D'Ambrosio F, Barbagallo Sangiorgi G.
    Clin Exp Allergy; 1995 Oct; 25(10):951-6. PubMed ID: 8556566
    [Abstract] [Full Text] [Related]

  • 2. Serum eosinophil cationic protein (ECP) as a marker of disease activity and treatment efficacy in seasonal asthma.
    Vatrella A, Ponticiello A, Parrella R, Romano L, Zofra S, DiLeva A, Bariffi F.
    Allergy; 1996 Aug; 51(8):547-55. PubMed ID: 8874658
    [Abstract] [Full Text] [Related]

  • 3. The relationship of serum-eosinophil cationic protein and eosinophil count to disease activity in children with bronchial asthma.
    Prehn A, Seger RA, Faber J, Torresani T, Molinari L, Gerber A, Sennhauser FH.
    Pediatr Allergy Immunol; 1998 Nov; 9(4):197-203. PubMed ID: 9920218
    [Abstract] [Full Text] [Related]

  • 4. The effect of salmeterol on the early- and late-phase reaction to bronchial allergen and postchallenge variation in bronchial reactivity, blood eosinophils, serum eosinophil cationic protein, and serum eosinophil protein X.
    Pedersen B, Dahl R, Larsen BB, Venge P.
    Allergy; 1993 Jul; 48(5):377-82. PubMed ID: 8103646
    [Abstract] [Full Text] [Related]

  • 5. Asthma therapy modulates priming-associated blood eosinophil responsiveness in allergic asthmatics.
    Grutters JC, Brinkman L, Aslander MM, van den Bosch JM, Koenderman L, Lammers JW.
    Eur Respir J; 1999 Oct; 14(4):915-22. PubMed ID: 10573242
    [Abstract] [Full Text] [Related]

  • 6. [The effect of salmeterol on the number of hypodense eosinophils, eosinophilic cationic protein levels ECP in serum, bronchial hyperresponsiveness and lung function test in patients with bronchial asthma].
    Chazan R, Grubek-Jaworska H, Hermanowicz-Salomon J, Droszcz W.
    Pol Merkur Lekarski; 1997 Oct; 3(16):180-2. PubMed ID: 9461726
    [Abstract] [Full Text] [Related]

  • 7. Comparison of anti-inflammatory and clinical effects of beclomethasone dipropionate and salmeterol in moderate asthma.
    Bacci E, Di Franco A, Bartoli ML, Carnevali S, Cianchetti S, Dente FL, Giannini D, Vagaggini B, Ruocco L, Paggiaro PL.
    Eur Respir J; 2002 Jul; 20(1):66-72. PubMed ID: 12166584
    [Abstract] [Full Text] [Related]

  • 8. A twelve month comparison of salmeterol with salbutamol in asthmatic patients. European Study Group.
    Britton MG, Earnshaw JS, Palmer JB.
    Eur Respir J; 1992 Oct; 5(9):1062-7. PubMed ID: 1426215
    [Abstract] [Full Text] [Related]

  • 9. Twelve month comparison of salmeterol and salbutamol as dry powder formulations in asthmatic patients. European Study Group.
    Lundback B, Rawlinson DW, Palmer JB.
    Thorax; 1993 Feb; 48(2):148-53. PubMed ID: 8493629
    [Abstract] [Full Text] [Related]

  • 10. Effects of low dose fluticasone/salmeterol combination on surrogate inflammatory markers in moderate persistent asthma.
    Currie GP, Syme-Grant NJ, McFarlane LC, Carey FA, Lipworth BJ.
    Allergy; 2003 Jul; 58(7):602-7. PubMed ID: 12823118
    [Abstract] [Full Text] [Related]

  • 11. Measurement of inflammatory mediators of eosinophils and lymphocytes in blood in acute asthma: serum levels of ECP influence the bronchodilator response.
    Di Lorenzo G, Pacor ML, Morici G, Drago A, Esposito-Pellitteri M, Candore G, Lo Bianco C, Caruso C.
    Int Arch Allergy Immunol; 2002 Apr; 127(4):308-15. PubMed ID: 12021550
    [Abstract] [Full Text] [Related]

  • 12. Effect of nasal triamcinolone acetonide on seasonal variations of bronchial hyperresponsiveness and bronchial inflammation in nonasthmatic children with seasonal allergic rhinitis.
    Orhan F, Sekerel BE, Adalioglu G, Pinar M, Tuncer A.
    Ann Allergy Asthma Immunol; 2004 Apr; 92(4):438-45. PubMed ID: 15104196
    [Abstract] [Full Text] [Related]

  • 13. Asthma control during long-term treatment with regular inhaled salbutamol and salmeterol.
    Taylor DR, Town GI, Herbison GP, Boothman-Burrell D, Flannery EM, Hancox B, Harré E, Laubscher K, Linscott V, Ramsay CM, Richards G.
    Thorax; 1998 Sep; 53(9):744-52. PubMed ID: 10319056
    [Abstract] [Full Text] [Related]

  • 14. Inhaled beclomethasone dipropionate (BDP) prevents seasonal changes in atopic asthmatics.
    Ponticiello A, Vatrella A, Parrella R, Romano L, Zofra S, Berlingieri GM, Bariffi F.
    Monaldi Arch Chest Dis; 1997 Apr; 52(2):112-7. PubMed ID: 9203805
    [Abstract] [Full Text] [Related]

  • 15. Salmeterol decreases eosinophilic cationic protein and rescue medication in patients inhaling beclomethasone dipropionate: preliminary study in mild and moderate asthma in Trinidad, West Indies.
    Pinto Pereira LM, Clement Y, Rouse J, Matthew J, Asgarali Z, Ramoutar D, Teelucksingh S.
    Int J Clin Pharmacol Res; 2003 Apr; 23(2-3):69-74. PubMed ID: 15025036
    [Abstract] [Full Text] [Related]

  • 16. Serum levels of eosinophil cationic protein and eosinophil protein x in pollen atopic patients with stable asthma and its relation with bronchial hyperresponsiveness.
    Chivato T, Martínez D, Blasco R, Melgarejo M, Gómez de Terreros FJ, Laguna R.
    Allergol Immunopathol (Madr); 1996 Apr; 24(6):243-7. PubMed ID: 9010559
    [Abstract] [Full Text] [Related]

  • 17. Asthma in children less than 5 years of age: eosinophils and serum levels of the eosinophil proteins ECP and EPX in relation to atopy and symptoms.
    Zimmerman B, Enander I, Zimmerman R, Ahlstedt S.
    Clin Exp Allergy; 1994 Feb; 24(2):149-55. PubMed ID: 8187030
    [Abstract] [Full Text] [Related]

  • 18. Effect of a single dose of salmeterol on the increase in airway eosinophils induced by allergen challenge in asthmatic subjects.
    Dente FL, Bancalari L, Bacci E, Bartoli ML, Carnevali S, Cianchetti S, Di Franco A, Giannini D, Vagaggini B, Testi R, Paggiaro PL.
    Thorax; 1999 Jul; 54(7):622-4. PubMed ID: 10377209
    [Abstract] [Full Text] [Related]

  • 19. Twelve months, treatment with inhaled salmeterol in asthmatic patients. Effects on beta 2-receptor function and inflammatory cells.
    Lötvall J, Lunde H, Ullman A, Törnqvist H, Svedmyr N.
    Allergy; 1992 Oct; 47(5):477-83. PubMed ID: 1362481
    [Abstract] [Full Text] [Related]

  • 20. Potential masking effects of salmeterol on airway inflammation in asthma.
    Mcivor RA, Pizzichini E, Turner MO, Hussack P, Hargreave FE, Sears MR.
    Am J Respir Crit Care Med; 1998 Sep; 158(3):924-30. PubMed ID: 9731027
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.